Skip to main content
NVDA+0.53%AAPL-0.87%GOOGL-1.59%MSFT-0.95%AMZN-1.89%TSM-0.99%SPCX-1.90%META+1.06%AVGO-0.96%TSLA+0.45%SKHY-0.24%BRK-B-0.01%LLY+0.55%MU+0.59%JPM-1.36%WMT-0.14%AMD+1.97%V-0.45%XOM+2.27%JNJ-0.98%ASMLa-1.22%0700.HK+1.90%MA-0.61%INTC+1.07%ABBV+0.31%1398.HK-2.09%CSCO+0.62%CVX+1.81%BAC-0.33%ORCL-1.01%COST-1.10%KO-0.98%DELL+3.86%CAT-0.38%HSBA.L-2.08%0005.HK-3.21%PG+0.41%UNH-1.56%LRCX-2.25%AP2d-2.19%AMAT-1.10%1816.HK-0.46%3988.HK-2.13%NFLX-2.73%GE-2.73%MS-1.88%0857.HK+0.60%HD-1.47%PM-0.25%0939.HK-2.83%USDJPY+1.02%NZDUSD-0.94%CHFJPY+0.78%USDTHB+0.71%GBPJPY+0.69%CADJPY+0.68%GBPNZD+0.64%NZDCHF-0.62%NZDCAD-0.61%AUDUSD-0.57%EURJPY+0.51%EURUSD-0.48%AUDJPY+0.47%EURNZD+0.47%PLNJPY+0.44%NOKJPY+0.43%GBPTRY+0.41%AUDNZD+0.38%USDCAD+0.33%NZDMXN-0.33%USDCHF+0.33%GBPHKD+0.32%SGDJPY+0.32%GBPUSD-0.31%GBPMXN-0.28%USDTRY+0.25%GBPAUD+0.24%AUDCHF-0.23%AUDCAD-0.22%USDSEK+0.21%USDSGD+0.19%EURCAD-0.17%USDILS+0.16%EURSEK+0.16%EURGBP-0.15%NZDSGD-0.15%EURCHF-0.14%EURSGD+0.14%GBPZAR-0.14%CHFNOK-0.13%EURCZK+0.11%EURAUD+0.10%USDNOK+0.08%AUDDKK-0.08%NZDJPY+0.08%USDCNH+0.07%USDPLN+0.07%GBPSGD+0.07%EURZAR-0.07%AUDSGD+0.06%AUDNOK-0.05%USDDKK+0.05%EURHKD-0.04%USDCOP-0.04%GBPCAD+0.03%EURNOK+0.03%CHFSGD-0.02%CADCHF-0.02%USDHKD+0.02%USDMXN+0.02%EURPLN+0.02%USDZAR-0.01%EURDKK-0.01%CHFSEK-0.01%EURCNH0.00%GBPCHF0.00%USOIL+2.54%W1+1.74%UKOIL+1.60%SUGAR-1.49%XNGUSD+1.25%COFFEE-1.07%COCOA-1.02%C1+1.01%S1+0.89%HG1+0.42%XAUUSD-0.30%GAUUSD-0.30%BTCUSD-2.73%ETHUSD-4.03%USDTUSD-0.03%XRPUSD-2.45%SOLUSD-3.23%TRXUSDT-0.44%ZECUSDT-3.95%DOGEUSD-2.29%XMRUSDT+0.75%LINKUSD-2.60%XLMUSD+0.50%BCHUSDT-1.43%UNIUSD-3.14%LTCUSD-2.62%HBARUSDT-0.18%TONUSD+26.79%SUIUSD-2.62%TAOUSDT-3.30%AAVEUSD-2.37%DOTUSDT-2.21%ICPUSDT-7.23%ONDOUSDT-3.37%WLDUSDT-1.56%ARBUSDT+4.73%ATOMUSDT-1.85%JUPUSDT-4.30%INJUSDT-9.68%STXUSDT-3.11%FETUSDT-4.35%PYTHUSDT-4.25%TIAUSDT-6.14%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-4.15%WIFUSDT-4.80%POLUSDT+0.48%IOTAUSDT-5.89%AXSUSDT-3.31%FARTCOINUSDT-1.65%EOSUSDT-4.51%DYDXUSDT-5.98%ORDIUSDT-2.12%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-14.59%NVDA+0.53%AAPL-0.87%GOOGL-1.59%MSFT-0.95%AMZN-1.89%TSM-0.99%SPCX-1.90%META+1.06%AVGO-0.96%TSLA+0.45%SKHY-0.24%BRK-B-0.01%LLY+0.55%MU+0.59%JPM-1.36%WMT-0.14%AMD+1.97%V-0.45%XOM+2.27%JNJ-0.98%ASMLa-1.22%0700.HK+1.90%MA-0.61%INTC+1.07%ABBV+0.31%1398.HK-2.09%CSCO+0.62%CVX+1.81%BAC-0.33%ORCL-1.01%COST-1.10%KO-0.98%DELL+3.86%CAT-0.38%HSBA.L-2.08%0005.HK-3.21%PG+0.41%UNH-1.56%LRCX-2.25%AP2d-2.19%AMAT-1.10%1816.HK-0.46%3988.HK-2.13%NFLX-2.73%GE-2.73%MS-1.88%0857.HK+0.60%HD-1.47%PM-0.25%0939.HK-2.83%USDJPY+1.02%NZDUSD-0.94%CHFJPY+0.78%USDTHB+0.71%GBPJPY+0.69%CADJPY+0.68%GBPNZD+0.64%NZDCHF-0.62%NZDCAD-0.61%AUDUSD-0.57%EURJPY+0.51%EURUSD-0.48%AUDJPY+0.47%EURNZD+0.47%PLNJPY+0.44%NOKJPY+0.43%GBPTRY+0.41%AUDNZD+0.38%USDCAD+0.33%NZDMXN-0.33%USDCHF+0.33%GBPHKD+0.32%SGDJPY+0.32%GBPUSD-0.31%GBPMXN-0.28%USDTRY+0.25%GBPAUD+0.24%AUDCHF-0.23%AUDCAD-0.22%USDSEK+0.21%USDSGD+0.19%EURCAD-0.17%USDILS+0.16%EURSEK+0.16%EURGBP-0.15%NZDSGD-0.15%EURCHF-0.14%EURSGD+0.14%GBPZAR-0.14%CHFNOK-0.13%EURCZK+0.11%EURAUD+0.10%USDNOK+0.08%AUDDKK-0.08%NZDJPY+0.08%USDCNH+0.07%USDPLN+0.07%GBPSGD+0.07%EURZAR-0.07%AUDSGD+0.06%AUDNOK-0.05%USDDKK+0.05%EURHKD-0.04%USDCOP-0.04%GBPCAD+0.03%EURNOK+0.03%CHFSGD-0.02%CADCHF-0.02%USDHKD+0.02%USDMXN+0.02%EURPLN+0.02%USDZAR-0.01%EURDKK-0.01%CHFSEK-0.01%EURCNH0.00%GBPCHF0.00%USOIL+2.54%W1+1.74%UKOIL+1.60%SUGAR-1.49%XNGUSD+1.25%COFFEE-1.07%COCOA-1.02%C1+1.01%S1+0.89%HG1+0.42%XAUUSD-0.30%GAUUSD-0.30%BTCUSD-2.73%ETHUSD-4.03%USDTUSD-0.03%XRPUSD-2.45%SOLUSD-3.23%TRXUSDT-0.44%ZECUSDT-3.95%DOGEUSD-2.29%XMRUSDT+0.75%LINKUSD-2.60%XLMUSD+0.50%BCHUSDT-1.43%UNIUSD-3.14%LTCUSD-2.62%HBARUSDT-0.18%TONUSD+26.79%SUIUSD-2.62%TAOUSDT-3.30%AAVEUSD-2.37%DOTUSDT-2.21%ICPUSDT-7.23%ONDOUSDT-3.37%WLDUSDT-1.56%ARBUSDT+4.73%ATOMUSDT-1.85%JUPUSDT-4.30%INJUSDT-9.68%STXUSDT-3.11%FETUSDT-4.35%PYTHUSDT-4.25%TIAUSDT-6.14%SEIUSDT-2.47%IMXUSDT-1.81%OPUSDT-1.70%GRTUSDT-4.15%WIFUSDT-4.80%POLUSDT+0.48%IOTAUSDT-5.89%AXSUSDT-3.31%FARTCOINUSDT-1.65%EOSUSDT-4.51%DYDXUSDT-5.98%ORDIUSDT-2.12%GALAUSDT-1.47%NOTUSDT-0.18%RONINUSDT-14.59%
IM

ICU Medical, Inc. (ICUI)

NASDAQ • Healthcare

$157.6
+$1.12 (+0.7%)
Market open

Last close at September 14, 2026 at 20:00 UTC

Open$157.63
Previous Close$157.6
Day Range$155.74 - $158.68
Avg. Volume (3M)230.8K
Market Cap$3.8B
P/E Ratio131.3
52 Week Range
$112.5$192.85
Next EarningsIn 51 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$551.6M100%
Gross Profitminus cost of goods$235M43%
Operating Incomeminus R&D and overhead$39.1M7%
Net Incomeminus taxes and the rest$19M3%

In plain terms: out of every $100 in revenue, ICU Medical, Inc. keeps $3 as net profit.

Fundamentals & Financials

Revenue (TTM)
$2.1B
Net Income (TTM)
$30M
EPS (TTM)
$1.2
ROA (TTM)
0.76%
Current Ratio
2.43
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+13.7%Q1 2026$1.91
+10.7%Q2 2026$1.97
+24.1%Q3 2026$2.37
Next

Nov 5

in 51 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +24.1%

ICU Medical beat expectations on both the top and bottom line in the second fiscal quarter of 2026, reported August 6, even as profits fell year over year. Revenue rose 0.5% to roughly $551.7 million (up from about $548.9 million a year ago) and topped the $533.4 million estimate (+3.4%), with Infusion Consumables, its largest segment, growing ~6% to about $289.3 million and Infusion Systems rising ~13% to around $189.0 million, while Vital Care declined ~32% to roughly $73.4 million. Adjusted EPS of $2.37 topped the $1.91 estimate (+24.1%). On profitability, gross profit was about $235.1 million with gross margin near 43%, and operating income came in around $39.1 million with operating margin roughly 7%. Net income fell 46% year over year to about $19.1 million (down from roughly $35.3 million a year ago), and the company generated operating cash flow of about $80.2 million. For the next period, consensus calls for EPS of $2.13 on revenue of $552.1 million.

View full earnings history

About ICU Medical, Inc.

ICU Medical, Inc. (NASDAQ: ICUI) makes hospital-focused medical devices and supplies for infusion therapy and critical care. In healthcare equipment and consumables, it sells globally across care settings and through wholesalers, serving hospitals, clinics, home-health, and long-term-care providers, and generated $2.2 billion of revenue in FY2025.

Name
ICU Medical, Inc.
CEO
Vivek Jain
Website
www.icumed.com
Industry
Healthcare
Year Founded
1984
Employees
13,000

Today's Snapshot

AI-generated

ICUI opened 0.5% lower at 156.79, while its sector was flat. ICU Medical discussed its infusion-pump cycle and margins at an investor conference hosted by Morgan Stanley, an investment bank.

Trading Volume

Below 10d avg (229.0K)

46.6K

vs S&P 500 Today

Underperforming Market

-0.96%

Updated: September 15, 2026 at 14:45 UTC

Technical Indicators

2 Buy1 Neutral5 Sell
ICUI registers a sell bias driven by clear downside momentum and negative MACD readings while short- to medium-term moving averages lie above the market, indicating recent selling pressure. ADX in the mid-20s points to a meaningful directional move, and volume measures are negative, supporting the bearish case, while the near-term oscillators are low and the pivot level sits above the current price. ATR is moderate so moves are not unusually volatile. Technical takeaway: the technicals favor a bearish posture with short-term pressure dominating despite longer-term moving averages being closer to price.
All signals
  • EMA (5 indicators)$148.76 - $166.69
    Sell
  • RSI (14)30.12
    Neutral
  • Stochastic %K (14, 3, 3)4.23
    Buy
  • MACD Level (12, 26)-4.05
    Sell

Peers & Related Assets

TVTXTravere Therapeutics, Inc.
$65.79-0.6%
HAEHaemonetics Corporation
$106.31+3.5%
LIVNLivaNova PLC
$80.63+3.1%
HTFLHeartflow, Inc. Common Stock
$49.54-0.7%
TARSTarsus Pharmaceuticals, Inc.
$79.95+0.8%
ARQTArcutis Biotherapeutics, Inc.
$24.27+1.6%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.